Free Government IBD Research Sources Patients Can Use

Content note: Educational content aligned with publicly available patient materials from the Crohn's & Colitis Foundation and other major IBD education sources. IBDPal is not affiliated with or endorsed by the Foundation. Last reviewed June 2026. Not individual medical advice.

Educational use only. IBDPal does not provide medical advice, diagnosis, or treatment. Always consult your gastroenterologist or IBD care team for personal decisions.

Good IBD education should make it easier to ask your gastroenterologist better questions, not make you feel like you need to become your own doctor. U.S. government health sites are useful because they are public, stable, and often written for patients.

Start with NIDDK for disease basics

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of NIH, has separate hubs for Crohn's disease and ulcerative colitis. These pages explain symptoms, diagnosis, treatment, eating and nutrition, and clinical trials in plain language.

Use MedlinePlus when you want one page with many links

MedlinePlus Crohn's disease and MedlinePlus ulcerative colitis collect summaries, tests, treatments, clinical trial links, journal article references, and patient handouts. MedlinePlus is produced by the National Library of Medicine.

Use CDC for public health context

The CDC's IBD basics page summarizes symptoms, complications, medication categories, and quality-of-life issues. The CDC's IBD facts and stats page summarizes U.S. prevalence estimates, health care cost patterns, and differences across groups.

Use ClinicalTrials.gov carefully

ClinicalTrials.gov is the official U.S. registry for clinical studies. It is useful for seeing what researchers are studying, but a listing is not a recommendation. Eligibility, risks, and study details must be discussed with your care team and study contacts.

FDA pages can help with treatment terminology

If your team mentions a biosimilar or interchangeable biologic, the FDA has a patient-friendly explainer on biosimilar and interchangeable biologics. It explains how biosimilars compare with reference biologics and why they may increase treatment options.

Licensing and reuse notes

Many government health summaries are public information, but not everything on a federal website is automatically reusable. Images, PDFs, videos, drug monographs, journal articles, or third-party material may have separate copyright rules. IBDPal summarizes in our own words and links to originals. If you reuse government content, check the page notice and give the requested acknowledgement.

How IBDPal uses these sources

We use government and clinical sources to check patient education pages, glossary definitions, nutrition baseline explanations, and research links. We do not copy protected third-party content or turn research summaries into personal medical advice.

Related: IBD research sources, trusted IBD resources, start-here roadmap, how IBDPal nutrition targets work.

Photos: Unsplash License (free use).

Medical Disclaimer

This article is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult your healthcare provider regarding dietary, medication, or lifestyle decisions.